What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Alliance for Clinical Trials in Oncology

Home
United States
Boston, MA
Alliance for Clinical Trials in Oncology

Alliance develops and conducts cancer clinical trials as part of NCI National Clinical Trials Network

10/18/2025

Rahul Aggarwal, MD, of UCSF Hellen Diller Family Comprehensive Cancer Center, to present a late-breaking abstract (LBA88) at tomorrow (Oct. 19) on final results from the Phase III PRESTO trial (AFT‑19), providing insights into the use of intensified androgen blockade in patients with high-risk biochemically relapsed prostate cancer (BRPC). Proffered Paper Session: LBA88

10/18/2025

Frank A. Sinicrope, MD, of Mayo Clinic, will present subgroup findings from the trial (Alliance A021502) in a poster session at , highlighting outcomes in patients with sporadic versus Lynch syndrome–related dMMR . Sunday, October 19.

10/17/2025

Don’t miss the Alliance Fall Group Meeting in Chicago, November 5–7! Join us in person or virtually to connect, collaborate, and advance cancer research. Register now: https://bit.ly/FallGrpMtg25

10/16/2025

Iyer Gopa, MD, of Memorial Sloan Kettering Cancer Center leads Alliance A031701, a clinical trial studying how chemotherapy medications gemcitabine hydrochloride and cisplatin work to treat patients with muscle invasive bladder cancer. Learn more at http://bit.ly/AllianceA031701.

10/15/2025

News release! Study by the Alliance for Clinical Trials in Oncology and the Acute Myeloid Leukemia Cooperative Group led by Ann-Kathrin Eisfeld, MD, associate professor of Internal Medicine and director of the Clara D. Bloomfield Center for Leukemia Outcomes Research at The Ohio State University, reveals that age-based classifications for treating acute myeloid leukemia may be outdated and overly simplistic. https://bit.ly/AML-Study

10/15/2025

Andrew Ko, MD, of the University of California San Francisco, and Erica Tsang, MD, of Princess Margaret Cancer Center, lead Alliance A022106 (PLATINUM) trial comparing two chemotherapy regimens to treat patients with metastatic pancreatic cancer and the BRCA1/2 or PALB2 mutations. To learn more, visit http://bit.ly/Alliance-A022106.

10/14/2025

Trial Tuesday! Haeseong Park, MD, MPH, of the Dana-Farber Cancer Institute, leads Alliance A022102 studying mFOLFIRINOX versus mFOLFOX with or without immunotherapy drug nivolumab for metastatic HER2 negative esophageal, gastroesophageal junction and gastric cancer. To learn more, visit https://bit.ly/Alliance-A022102.

10/13/2025

Eric Miller, MD, PhD, of Ohio State University Cancer Center leads Alliance A022101, the ERAsur trial, that explores if adding radiation, heat therapy or surgery can extend survival for people with metastatic colorectal cancer. To learn more, visit https://bit.ly/Alliance-A022101.

10/10/2025

Thomas Hope, MD, from the University of California San Francisco and Sukhmani Paddi, MD, from Cedars-Sinai lead A021901/B-LuRE trial comparing radioactive medication lutetium Lu 177 dotatate against the usual treatment of chemotherapy drug everolimus in patients with bronchial neuroendocrine tumors. Learn more at https://bit.ly/Alliance-A021901.

10/09/2025

Cristina R. Ferrone, MD, from Harvard Medical Center leads Alliance A021806 investigating if giving chemotherapy before and after surgery (perioperatively) works better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).

10/08/2025

New trial! Angela R. Bradbury, MD, of the Perelman School of Medicine at the University of Pennsylvania leads Alliance A232301CD testing if a digital chatbot intervention is as effective as standard remote genetic services in increasing counseling uptake among adolescent and young (AYA) adult cancer patients. To learn more, visit https://bit.ly/AllianceA232301CD.

10/07/2025

For Trial Tuesday, radiation oncologist Dean Shumway, MD, of the Mayo Clinic leads Alliance A012301 (LoTam) comparing the effect of low-dose tamoxifen to usual hormonal therapy in treating post-menopausal women with early-stage HER2 breast cancer. Learn more at https://bit.ly/Alliance-A012301.

Address

Alliance For Clinical Trials In Oncology, Office Of The Group Chair 221 Longwood Avenue, Room 108
Boston, MA
02115

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+16177328919

Website

http://www.AllianceforClinicalTrialsinOncology.org/

Alerts

Be the first to know and let us send you an email when Alliance for Clinical Trials in Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.